<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586592/" ref="ordinalpos=4338&amp;ncbi_uid=1634084&amp;link_uid=PMC2586592" image-link="/pmc/articles/PMC2586592/figure/F4/" class="imagepopup">Fig. 4.  From: ?E-catenin is not a significant regulator of ?-catenin <span class="highlight" style="background-color:">signaling</span> in the developing mammalian brain. </a></div><br /><div class="p4l_captionBody">Transition from E12.5 to E13.5 results in extensive hyperplasia without significant changes in expression of endogenous transcriptional targets of β-catenin signaling pathway. (A) Hyperplasia in E13.5 αE-catenin−/− brains. Total cells were isolated from E12.5 and E13.5 wild-type (WT) and αE-catenin−/− brains and counted using Coulter Counter. Data represent means ± SD. n=3 to 5. Asterisk indicates statistically significant difference with P&lt;0.0001. (B) qPCR analysis of β-catenin pathway transcripts c-myc, Cyclin D1, Axin2 in E12.5 and E13.5 heterozygous and αE-catenin−/− brains. The levels of expression are shown in arbitrary units with mean of levels in heterozygous embryos adjusted to one. Data represent means ± SD. n=4.</div></div>